1
|
Jemal A, Murray T, Ward E, et al: Cancer
statistics, 2005. CA Cancer J Clin. 55:10–30. 2005. View Article : Google Scholar
|
2
|
Million RR: Cancer of the head and neck.
Cancer: Principles and Practice of Oncology. De Vita VT Jr, Hellman
S and Rosenberg SA: 1. 4th edition. JB Lippincott; Philadelphia,
PA: pp. 396–420. 1992
|
3
|
Brieger J, Jacob R, Riazimand HS, Essig E,
Heinrich UR, Bittinger F and Mann WJ: Chromosomal aberrations in
premalignant and malignant squamous epithelium. Cancer Genet
Cytogenet. 144:148–155. 2003. View Article : Google Scholar : PubMed/NCBI
|
4
|
Welkoborsky HJ, Hinni M, Dienes HP and
Mann WJ: Predicting recurrence and survival in patients with
laryngeal cancer by means of DNA cytometry, tumor front grading,
and proliferation markers. Ann Otol Rhinol Laryngol. 104:503–510.
1995. View Article : Google Scholar : PubMed/NCBI
|
5
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View
Article : Google Scholar
|
6
|
Torre GC: SCC antigen in malignant and
nonmalignant squamous lesions. Tumour Biol. 19:517–526. 1998.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Kureishy N, Sapountzi V, Prag S, Anilkumar
N and Adams JC: Fascins, and their roles in cell structure and
function. Bioessays. 24:350–361. 2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Karasavvidou F, Barbanis S, Pappa D,
Moutzouris G, Tzortzis V, Melekos MD and Koukoulis G: Fascin
determination in urothelial carcinomas of the urinary bladder: a
marker of invasiveness. Arch Pathol Lab Med. 132:1912–1915.
2008.PubMed/NCBI
|
9
|
Hashimoto Y, Skacel M, Lavery IC,
Mukherjee AL, Casey G and Adams JC: Prognostic significance of
fascin expression in advanced colorectal cancer: an
immunohistochemical study of colorectal adenomas and
adenocarcinomas. BMC Cancer. 6:2412006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yoder BJ, Tso E, Skacel M, et al: The
expression of fascin, an actin-bundling motility protein,
correlates with hormone receptor-negative breast cancer and a more
aggressive clinical course. Clin Cancer Res. 11:186–192. 2005.
|
11
|
Hu W, McCrea PD, Deavers M, Kavanagh JJ,
Kudelka AP and Verschraegen CF: Increased expression of fascin,
motility associated protein, in cell cultures derived from ovarian
cancer and in borderline and carcinomatous ovarian tumors. Clin Exp
Metastasis. 18:83–88. 2000. View Article : Google Scholar : PubMed/NCBI
|
12
|
Hashimoto Y, Shimada Y, Kawamura J,
Yamasaki S and Imamura M: The prognostic relevance of fascin
expression in human gastric carcinoma. Oncology. 67:262–270. 2004.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Maitra A, Iacobuzio-Donahue C, Rahman A,
et al: Immunohistochemical validation of a novel epithelial and a
novel stromal marker of pancreatic ductal adenocarcinoma identified
by global expression microarrays: sea urchin fascin homolog and
heat shock protein 47. Am J Clin Pathol. 118:52–59. 2002.
View Article : Google Scholar
|
14
|
Lee TK, Poon RT, Man K, et al: Fascin
over-expression is associated with aggressiveness of oral squamous
cell carcinoma. Cancer Lett. 254:308–315. 2007. View Article : Google Scholar : PubMed/NCBI
|
15
|
Chen SF, Yang SF, Li JW, et al: Expression
of fascin in oral and oropharyngeal squamous cell carcinomas has
prognostic significance - a tissue microarray study of 129 cases.
Histopathology. 51:173–183. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wu D, Chen L, Liao W, Ding Y, Zhang Q, Li
Z and Liu L: Fascin1 expression predicts poor prognosis in patients
with nasopharyngeal carcinoma and correlates with tumor invasion.
Ann Oncol. 21:589–596. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zou J, Yang H, Chen F, et al: Prognostic
significance of fascin-1 and E-cadherin expression in laryngeal
squamous cell carcinoma. Eur J Cancer Prev. 19:11–17. 2010.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Brieger J, Duesterhoeft A, Brochhausen C,
Gosepath J, Kirkpatrick CJ and Mann WJ: Recurrence of pleomorphic
adenoma of the parotid gland - predictive value of cadherin-11 and
fascin. APMIS. 116:1050–1057. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hashimoto Y, Parsons M and Adams JC: Dual
actin-bundling and protein kinase C-binding activities of fascin
regulate carcinoma cell migration downstream of rac and contribute
to metastasis. Mol Biol Cell. 18:4591–4602. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Schuon R, Brieger J, Heinrich UR, Roth Y,
Szyfter W and Mann WJ: Immunohistochemical analysis of growth
mechanisms in juvenile nasopharyngeal angiofibroma. Eur Arch
Otorhinolaryngol. 264:389–394. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Bittinger F, Brochhausen C, Köhler H, et
al: Differential expression of cell adhesion molecules in inflamed
appendix: correlation with clinical stage. J Pathol. 186:422–428.
1998. View Article : Google Scholar : PubMed/NCBI
|
22
|
Vignjevic D, Schoumacher M, Gavert N, et
al: Fascin, a novel target of beta-catenin-TCF signaling, is
expressed at the invasive front of human colon cancer. Cancer Res.
67:6844–6853. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Adams JC: Fascin protrusions in cell
interactions. Trends Cardiovasc Med. 14:221–226. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Yamashiro S, Yamakita Y, Ono S and
Matsumura F: Fascin, an actin-bundling protein, induces membrane
protrusions and increases cell motility of epithelial cells. Mol
Biol Cell. 9:993–1006. 1998. View Article : Google Scholar : PubMed/NCBI
|
25
|
Brieger J, Kastner J, Gosepath J and Mann
WJ: Evaluation of microsatellite amplifications at chromosomal
locus 3q26 as surrogate marker for premalignant changes in mucosa
surrounding head and neck squamous cell carcinoma. Cancer Genet
Cytogenet. 167:26–31. 2006. View Article : Google Scholar
|
26
|
Takikita M, Hu N, Shou JZ, et al: Fascin
and CK4 as biomarkers for esophageal squamous cell carcinoma.
Anticancer Res. 31:945–952. 2011.PubMed/NCBI
|